01 1Inga Pharmaceuticals
02 1Professional Compounding Centers of America dba PCCA
01 1BELLADONNA
02 1Belladonna Extract
01 1India
02 1United Kingdom
NDC Package Code : 63570-010
Start Marketing Date : 2000-03-01
End Marketing Date : 2024-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 51927-1120
Start Marketing Date : 2013-06-25
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT FOR HUMAN P...
A Belladonna Leaf Extract manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Belladonna Leaf Extract, including repackagers and relabelers. The FDA regulates Belladonna Leaf Extract manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Belladonna Leaf Extract API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Belladonna Leaf Extract manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Belladonna Leaf Extract supplier is an individual or a company that provides Belladonna Leaf Extract active pharmaceutical ingredient (API) or Belladonna Leaf Extract finished formulations upon request. The Belladonna Leaf Extract suppliers may include Belladonna Leaf Extract API manufacturers, exporters, distributors and traders.
click here to find a list of Belladonna Leaf Extract suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Belladonna Leaf Extract as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for Belladonna Leaf Extract API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture Belladonna Leaf Extract as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain Belladonna Leaf Extract and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Belladonna Leaf Extract NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of Belladonna Leaf Extract suppliers with NDC on PharmaCompass.
We have 2 companies offering Belladonna Leaf Extract
Get in contact with the supplier of your choice:
LOOKING FOR A SUPPLIER?
